EYPT

EYPT

USD

EyePoint Pharmaceuticals Inc. Common Stock

$12.390+0.260 (2.143%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$12.130

Hoch

$12.950

Tief

$11.960

Volumen

4.59M

Unternehmensfundamentaldaten

Marktkapitalisierung

1.0B

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.08M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $3.91Aktuell $12.390Hoch $14.91

Ähnliche Nachrichten

GlobeNewswire

EyePoint Announces Pricing of Public Offering

WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with

Mehr anzeigen
EyePoint Announces Pricing of Public Offering
GlobeNewswire

EyePoint Announces Proposed Public Offering of Common Stock

WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with

Mehr anzeigen
EyePoint Announces Proposed Public Offering of Common Stock
GlobeNewswire

EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema

– DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New preclinical data

Mehr anzeigen
EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema